Pharmacological factors affecting accumulation of gemcitabine's active metabolite, gemcitabine triphosphate
PHARMACOGENOMICS (2017)
Journal
PHARMACOGENOMICS
Volume 18, Issue 9, Pages 911-925Publisher
FUTURE MEDICINE LTD
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
Takeshi Matsumoto, Takashi Komori, Yuta Yoshino, Tadaaki Ioroi, Tsukasa Kitahashi, Hiromu Kitahara, Kohei Ono, Tamami Higuchi, Masayo Sakabe, Hiroshi Kori, Masahiro Kano, Ritsuko Hori, Yukio Kato, Shinji Hagiwara
PHARMACEUTICAL RESEARCH (2021)
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study
Ursula A. Matulonis, Helen Q. Huang, Virginia L. Filiaci, Marcus Randall, Paul A. DiSilvestro, Katherine M. Moxley, Jeffrey M. Fowler, Matthew A. Powell, Nick M. Spirtos, Krishnansu S. Tewari, William E. Richards, John M. Nakayama, David G. Mutch, David S. Miller, Daniela Matei, Lari B. Wenzel
GYNECOLOGIC ONCOLOGY (2022)
Comparison of gemcitabine/carboplatin versus paclitaxel/cisplatin for the management of non-small cell lung cancer
Wei Wang, Wenli Li, Lili Dai, Lei Zhao, Kaixin Qu
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2022)
Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma
Kazuma Sugimoto, Satoru Taguchi, Kenjiro Kishitani, Taketo Kawai, Kazuki Masuda, Yu Nakamura, Manami Kinjo, Mitsuhiro Tambo, Jimpei Miyakawa, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tohru Nakagawa, Hiroshi Fukuhara, Haruki Kume
BMC UROLOGY (2022)
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M. H. Einerhand, Anna J. Black, Homayoun Zargar, Adrian S. Fairey, Colin P. Dinney, Maria C. Mir, Laura-Maria Krabbe, Michael S. Cookson, Niels-Erik Jacobson, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Wassim Kassouf, Marc A. Dall'Era, Srikala S. Sridhar, Jonathan S. McGrath, Jonathan Aning, Shahrokh F. Shariat, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Petros Grivas, Jorge A. Garcia, Andrew J. Stephenson, Jay B. Shah, Siamak Daneshmand, Kamran Zargar-Shoshtari, Philippe E. Spiess, Bas W. G. van Rhijn, Peter C. Black, Laura S. Mertens
WORLD JOURNAL OF UROLOGY (2022)
Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
Shinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, Satoyo Otsuka, Makio Shozu
CANCERS (2021)
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel Clarke-Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca Baergen
JOURNAL OF CLINICAL ONCOLOGY (2023)
New Heights for ProTides?
Carlo Ballatore
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, Arif Hakan Onder, Fatih Kose, Caglayan Geredeli, Mustafa Karaagac, Muhammet Ali Kaplan, Mevlude Inanc, Sabin Goktas Aydin, Aysegul Kargi, Haci Arak, Banu Ozturk, Ali Ayberk Besen, Oguzhan Selvi, Mustafa Korkmaz, Zeynep Oruc, Oktay Bozkurt, Ahmet Bilici, Selami Bayram, Shute Ailia Dae, Mustafa Ozdogan, Hasan Senol Coskun, Sema Sezgin Goksu
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma
M. S. van der Heijden, G. Sonpavde, T. Powles, A. Necchi, M. Burotto, M. Schenker, J. P. Sade, A. Bamias, P. Beuzeboc, J. Bedke, J. Oldenburg, G. Chatta, Y. Urun, D. Ye, Z. He, B. P. Valderrama, J. H. Ku, Y. Tomita, J. Filian, L. Wang, D. Purcea, M. Y. Patel, F. Nasroulah, M. D. Galsky
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Di Maria Jiang, Hao-Wen Sim, Osvaldo Espin-Garcia, Bryan A. Chan, Akina Natori, Charles H. Lim, Stephanie Moignard, Eric X. Chen, Geoffrey Liu, Gail Darling, Carol J. Swallow, Savtaj Brar, James Brierley, Jolie Ringash, Rebecca Wong, John Kim, Patrik Rogalla, Sara Hafezi-Bakhtiari, Jennifer J. Knox, Raymond W. Jang, Elena Elimova
ONCOLOGY (2021)
Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma
Sung Hoon Choi, Incheon Kang, Sung Hwan Lee, Beodeul Kang, Jaekyung Cheon, Dae Jung Kim, Gwangil Kim, Chang -Il Kwon, Kwang Hyun Ko, Hong Jae Chon
SURGERY (2023)
Randomized phase II trial of carboplatin plus nab-paclitaxel versus cisplatin plus gemcitabine for chemotherapy-naive squamous cell carcinoma: North Japan lung cancer study group 1302
Yosuke Kawashima, Toshiyuki Harada, Yuka Fujita, Taku Nakagawa, Kana Watanabe, Naoto Morikawa, Kei Takamura, Kenya Kanazawa, Tomoya Kuda, Kazuhiro Usui, Akimasa Sekine, Akira Inoue, Shunichi Sugawara
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy
Zhen-Chong Yang, Chao-Chao Du, Ting Liu, Li-Ting Liu, Qiu-Yan Chen, Shan-Shan Guo, Hai-Qiang Mai
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)
Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan, Yongtao Han, Xuefeng Leng, Lin Peng, Qifeng Wang
RADIATION ONCOLOGY (2022)
Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment
Lenka N. C. Boyd, Katarina D. Andini, Godefridus J. Peters, Geert Kazemier, Elisa Giovannetti
SEMINARS IN CANCER BIOLOGY (2022)
Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
I. Gede Putu Supadmanaba, Giulia Mantini, Ornella Randazzo, Mjriam Capula, Ittai B. Muller, Stella Cascioferro, Patrizia Diana, Godefridus J. Peters, Elisa Giovannetti
EPIGENETICS (2022)
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
Myra E. van Linde, Mariette Labots, Cyrillo G. Brahm, Koos E. Hovinga, Philip C. De Witt Hamer, Richard J. Honeywell, Richard De Goeij-de Haas, Alex A. Henneman, Jaco C. Knol, Godefridus J. Peters, Henk Dekker, Sander R. Piersma, Thang Pham, William P. Vandertop, Connie R. Jimenez, Henk M. W. Verheul
CLINICAL CANCER RESEARCH (2022)
The Influence of Mitochondrial Energy and 1C Metabolism on the Efficacy of Anticancer Drugs: Exploring Potential Mechanisms of Resistance
Marika Franczak, Isabel Toenshoff, Gerrit Jansen, Ryszard T. Smolenski, Elisa Giovannetti, Godefridus J. Peters
CURRENT MEDICINAL CHEMISTRY (2023)
The Use of Pregnancy Physiologically Based Pharmacokinetic Modeling for Renally Cleared Drugs
Paola Coppola, Essam Kerwash, Susan Cole
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Pharmacokinetic data in pregnancy: A review of available literature data and important considerations in collecting clinical data
Paola Coppola, Essam Kerwash, Janet Nooney, Amro Omran, Susan Cole
FRONTIERS IN MEDICINE (2022)
Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library
Motahareh Mortazavi, Elaheh Raufi, Tahereh Damghani, Mehdi Khoshneviszadeh, Najmeh Edraki, Masoomeh Eskandari, Elisa Giovannetti, Godefridus J. Peters, Somayeh Pirhadi, Omidreza Firuzi
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo
M. Houweling, U. K. Abdul, C. Brahm, T. Lagerweij, S. Heukelom, P. W. Koken, R. Honeywell, L. E. Wedekind, G. J. Peters, H. Verheul, P. Sminia, D. Noske, T. Wurdinger, B. A. Westerman
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Federica Borea, Marika A. Franczak, Maria Garcia, Matteo Perrino, Nadia Cordua, Ryszard T. Smolenski, Godefridus J. Peters, Rafal Dziadziuszko, Armando Santoro, Paolo A. Zucali, Elisa Giovannetti
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma
Marika A. Franczak, Oliwia Krol, Gabriela Harasim, Agata Jedrzejewska, Nadia Zaffaroni, Carlotta Granchi, Filippo Minutolo, Amir Avan, Elisa Giovannetti, Ryszard T. Smolenski, Godefridus J. Peters
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Use of Physiologically Based Pharmacokinetic Modeling for Hepatically Cleared Drugs in Pregnancy: Regulatory Perspective
Paola Coppola, Essam Kerwash, Susan Cole
JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
Mahrou Vahabi, Bilal Dehni, Ines Antomas, Elisa Giovannetti, Godefridus J. Peters
CANCER AND METASTASIS REVIEWS (2023)
Looking for the unexpected in purine and pyrimidine metabolism
Lars Petter Jordheim, Caius G. Radu, Godefridus J. Peters
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2023)
The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach
Alireza Asadnia, Elham Nazari, Ladan Goshayeshi, Nima Zafari, Mehrdad Moetamani-Ahmadi, Lena Goshayeshi, Haneih Azari, Ghazaleh Pourali, Ghazaleh Khalili-Tanha, Mohammad Reza Abbaszadegan, Fatemeh Khojasteh-Leylakoohi, Mohammadjavad Bazyari, Mir Salar Kahaei, Elnaz Ghorbani, Majid Khazaei, Seyed Mahdi Hassanian, Ibrahim Saeed Gataa, Mohammad Ali Kiani, Godefridus J. Peters, Gordon A. Ferns, Jyotsna Batra, Alfred King-yin Lam, Elisa Giovannetti, Amir Avan
CANCERS (2023)
Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy
Paola Coppola, Andrew Butler, Susan Cole, Essam Kerwash
PHARMACEUTICS (2023)